We use cookies for a better user experience. Read our Privacy Policy

I Agree

Contraceptives Market

Contraceptives Market (Product: Contraceptive Drugs and Contraceptive Devices; and Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Contraceptives Market Outlook 2028

  • The global contraceptives market was valued at US$ 893.9 Mn in 2020
  • It is estimated to expand at a CAGR of 15.5% from 2021 to 2028
  • The global contraceptives market is expected to cross the value of US$ 2.7 Bn by the end of 2028

Analysts’ Viewpoint on Contraceptives Market Scenario

Birth spacing methods amid the ongoing COVID-19 pandemic include precise advice on lactation amenorrhoea method (LAM) to enhance its efficacy, barrier methods such as condoms, and plentiful supplies of oral progestin-only pill, among others. The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players. Since there is a lack of awareness about the advantages of contraceptives in developing economies, market stakeholders should initiate collaborative agreements with governments to educate women as well as related individuals about different alternatives. Manufacturers should increase the production of affordable contraceptive options to boost their uptake in developing economies.

High Prevalence of Sexually Transmitted Infections Propels Demand for Contraceptives

A number of international and national organizations have initiated STI (sexually transmitted infections) awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.

Increase in adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptives market. People across the world have become more aware about the need of family planning.

Request a sample to get extensive insights into the Contraceptives Market

Birth Spacing Helps Reduce Burden on Healthcare Systems amid COVID-19 Pandemic

The COVID-19 pandemic has heightened the importance for family planning since most people have been spending time indoors. Manufacturers in the contraceptives market are capitalizing on this opportunity to ensure uninterrupted supply of oral contraceptives, contraceptive injectables, and contraceptive devices. Healthcare organizations are stressing on the advantages of birth spacing during the ongoing pandemic, since avoiding pregnancy during such uncertain times is wise for women not only on a personal level but also from a public health perspective in terms of not adding to overburdened healthcare systems. Manufacturers are increasing efforts to prevent stock-outs for implants, oral contraceptive pills, and copper intrauterine devices.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Comprehensive Product Portfolio Allows Stakeholders to Expand Income Sources

The contraceptives market is likely to provide new vendors significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the market.

Oral (pill) contraceptives, topical contraceptives, and injectable contraceptives are various types of contraceptives. Contraceptive devices, on the other hand, include condoms, intrauterine devices (IUD), vaginal rings, implants, patches, diaphragms, sponges, etc. The barrier method, particularly condoms, is the most common form of artificial contraception.

The global contraceptives market is expected to be driven by increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Contraceptives Market

Lack of Knowledge about Advantages of Contraceptives Hampers Market Growth

Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women of Asia use modern contraception at a lower rate than the global average. In Asia, majority of unintended pregnancies is caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion.

Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in this market. Hence, participants in the market should collaborate with governments to increase awareness about the advantages of contraceptives, which holds potential to boost product sales.

U.S. Sets Benchmark for Contraceptive Innovation and Collaborative Agreements

Key players in the global contraceptives market are engaged in regulatory approvals, innovations in technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptives market. A few expansion strategies adopted by players operating in the global contraceptives market are announcing the generic versions of vaginal ring in the U.S. The launch of such vaginal rings can be expected to drive the contraceptives market.

Healthcare organizations are launching global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market. At the same time, manufacturers are investing in R&D to increase availability of FDA (Food and Drug Administration)-approved contraceptive options.

Contraceptives Market: Overview

  • According to Transparency Market Research’s latest report on the global contraceptives market for the historical period 2017–2018 and forecast period 2019–2027, decline in prices and increase in access to contraceptives are projected to drive the global contraceptives market during the forecast period

Rise in Prevalence of Sexually Transmitted Diseases Drives Demand for Contraceptive Tablets and Other Forms of Contraception

  • A number of international and national organizations have initiated STI awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.
  • Increase in adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptives market. People across the world have become more aware about the need of family planning.

Entry of New Vendors with Advanced Contraceptive Methods: Key Driver

  • The global contraceptives market is likely to provide new vendors significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the global contraceptives market.

Lack of Awareness about Application of Contraceptive Devices in Emerging Countries

  • Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women of Asia use modern contraception at a lower rate than the global average.
  • In Asia, majority of unintended pregnancies are caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion
  • Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in the global contraceptives market.

Contraceptives Market: Competition Landscape

  • This report profiles major players in the global contraceptives market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players
  • Leading players operating in the global contraceptives market are
    • Merck & Co., Inc., Cipla, Inc.
    • Allergan plc
    • Bayer AG
    • HLL Lifecare Limited
    • Mankind Pharma
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mithra Pharmaceuticals
    • Janssen Pharmaceutical Company
    • Reckitt Benckiser Group plc., etc.

Contraceptives Market: Key Developments

  • Key players in the global contraceptives market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptives market. A few expansion strategies adopted by players operating in the global contraceptives market are:
    • On January 14, 2021, Teva Pharmaceuticals announced the generic version of NuvaRing (etonogestrel and ethinyl estradiol) vaginal ring in the U.S. The launch of such vaginal rings can be expected to drive the contraceptives market.
    • On November 17, 2020, the World Health Organization launched global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market.
    • On May 22, 2020, Evofem Biosciences, Inc. announced that the U.S. Food and Drug Administration had approved Phexxi, a new contraceptive method
  • The report on the global contraceptives market discussed individual strategies, followed by company profiles of manufacturers of contraceptives devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global contraceptives market.

Contraceptives Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 893.9 Mn

Market Forecast Value in 2028

US$ 2,764.7 Mn

Growth Rate (CAGR)

15.5%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Product
    • Contraceptive Drugs
      • Oral Contraceptives
        • Combined Contraceptives
        • Mini-pills
      • Contraceptive Injectable
      • Topical Contraceptive Patch
    • Contraceptive Devices
      • Male Contraceptive Devices
      • Female Contraceptive Devices
        • Female Condoms
        • Contraceptive Diaphragms
        • Contraceptive Sponges
        • Contraceptive Vaginal Rings
        • Intrauterine Devices
        • Sub-dermal Contraceptives Implants
        • Non-Surgical Permanent Contraception Devices
  • Contraceptives Market, by Distribution Channel
    • Hospitals Pharmacies
      • Public
      • Private
    • Independent Pharmacies
    • Online Pharmacies
    • Clinics
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Merck & Co., Inc.
  • Cipla Inc.
  • Allergan plc
  • Bayer AG
  • HLL Lifecare Limited
  • Mankind Pharma
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mithra Pharmaceuticals
  • Janssen Pharmaceutical Company
  • Reckitt Benckiser Group plc.
  • Other Prominent Players.

Customization Scope

Available upon request

Pricing

Available upon request

Contraceptives Market – Segmentation

Product
  • Contraceptive Drugs
    • Oral Contraceptives
      • Combined Contraceptives
      • Mini-pills
    • Contraceptive Injectable
    • Topical Contraceptive Patch
  • Contraceptive Devices
    • Male Contraceptive Devices
    • Female Contraceptive Devices
  • Tissue Engineering
Distribution Channel
  • Hospitals Pharmacy
    • Public
    • Private
  • Independent Pharmacy
  • Online Platform
  • Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Contraceptives Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of contraceptives market?

Contraceptives market is expected to cross the value of US$ 2.7 Bn by the end of 2028

What is the anticipated CAGR of the contraceptives market in the forecast period?

Contraceptives market is estimated to expand at a CAGR of 15.5% from 2021 to 2028

What are the key driving factors for the growth of the contraceptives market?

Contraceptives market is driven by increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies

Which region is expected to project the highest market share in the global contraceptives market?

North America dominated the global contraceptives market and the region is expected to account for major share of the global market during the forecast period

Who are the key players in the global contraceptives market?

Key players in the global contraceptives market include Smith & Nephew plc, Anika Therapeutics, Inc., DePuy Synthes, Inc., Baxter International, Inc., Stryker Corporation, Medtronic, Inc., Arthrex, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Contraceptives Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Key Market Indicators

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity

    4.5. Global Contraceptives Market Analysis and Forecast, 2017–2028

        4.5.1. Market Revenue Projections (US$ Mn)

    4.6. Global Contraceptives Market - Global Supply Demand Scenario

    4.7. Porter’s Five Force Analysis

    4.8. Value Chain Analysis

    4.9. Market Outlook

5. Global Contraceptives Market Analysis and Forecast, By Product

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value Forecast, by Product, 2017–2028

        5.4.1. Contraceptives Drugs

            5.4.1.1. Oral Contraceptives

                5.4.1.1.1. Combined Contraceptives

                5.4.1.1.2. Mini-pills

            5.4.1.2. Contraceptive Injectable

            5.4.1.3. Topical Contraceptive Patch

        5.4.2. Contraceptive Devices

            5.4.2.1. Male Contraceptive Devices

            5.4.2.2. Female Contraceptive Devices

                5.4.2.2.1. Female Condoms

                5.4.2.2.2. Contraceptive Diaphragms

                5.4.2.2.3. Contraceptive Sponges

                5.4.2.2.4. Contraceptive Vaginal Rings

                5.4.2.2.5. Intrauterine Devices

                5.4.2.2.6. Sub-dermal Contraceptives Implants

                5.4.2.2.7. Non-Surgical Permanent Contraception Devices

    5.5. Market Attractiveness Analysis, By Product

6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value Forecast, by Distribution Channel, 2017–2028

        6.4.1. Hospital Pharmacy

            6.4.1.1. Public

            6.4.1.2. Private

        6.4.2. Independent Pharmacy

        6.4.3. Online Platform

        6.4.4. Clinics

        6.4.5. Others

    6.5. Market Attractiveness Analysis, By Distribution Channel

7. Global Contraceptives Market Analysis and Forecast, By Region

    7.1. Key Findings

    7.2. Policies and Regulations

    7.3. Market Value Forecast, by Region

        7.3.1. North America

        7.3.2. Europe

        7.3.3. Asia Pacific

        7.3.4. Latin America

        7.3.5. Middle East and Africa

    7.4. Market Attractiveness Analysis, By Country/Region

8. North America Contraceptives Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

        8.1.2. Policies and Regulations

        8.1.3. Key Trends

    8.2. Market Value Forecast, by Product, 2017–2028

        8.2.1. Contraceptive Drugs

            8.2.1.1. Oral Contraceptives

                8.2.1.1.1. Combined Contraceptives

                8.2.1.1.2. Mini-pills

            8.2.1.2. Contraceptive Injectable

            8.2.1.3. Topical Contraceptive Patch

        8.2.2. Contraceptive Devices

            8.2.2.1. Male Contraceptive Devices

            8.2.2.2. Female Contraceptive Devices

                8.2.2.2.1. Female Condoms

                8.2.2.2.2. Contraceptive Diaphragms

                8.2.2.2.3. Contraceptive Sponges

                8.2.2.2.4. Contraceptive Vaginal Rings

                8.2.2.2.5. Intrauterine Devices

                8.2.2.2.6. Sub-dermal Contraceptives Implants

                8.2.2.2.7. Non-Surgical Permanent Contraception Devices

    8.3. Market Value Forecast, by Distribution Channel, 2017–2028

        8.3.1. Hospital Pharmacy

            8.3.1.1. Public

            8.3.1.2. Private

        8.3.2. Independent Pharmacy

        8.3.3. Online Platform

        8.3.4. Clinics

        8.3.5. Others

    8.4. Market Value Forecast, by Country, 2017–2028

        8.4.1. U.S.

        8.4.2. Canada

    8.5. Market Attractiveness Analysis

        8.5.1. By Product

        8.5.2. By Distribution Channel

        8.5.3. By Country

9. Europe Contraceptives Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

        9.1.2. Policies and Regulations

        9.1.3. Key Trends

    9.2. Market Value Forecast, by Product, 2017–2028

        9.2.1. Contraceptive Drugs

            9.2.1.1. Oral Contraceptives

                9.2.1.1.1. Combined Contraceptives

                9.2.1.1.2. Mini-pills

            9.2.1.2. Contraceptive Injectable

            9.2.1.3. Topical Contraceptive Patch

        9.2.2. Contraceptive Devices

            9.2.2.1. Male Contraceptive Devices

            9.2.2.2. Female Contraceptive Devices

                9.2.2.2.1. Female Condoms

                9.2.2.2.2. Contraceptive Diaphragms

                9.2.2.2.3. Contraceptive Sponges

                9.2.2.2.4. Contraceptive Vaginal Rings

                9.2.2.2.5. Intrauterine Devices

                9.2.2.2.6. Sub-dermal Contraceptives Implants

                9.2.2.2.7. Non-Surgical Permanent Contraception Devices

    9.3. Market Value Forecast, by Distribution Channel, 2017–2028

        9.3.1. Hospital Pharmacy

            9.3.1.1. Public

            9.3.1.2. Private

        9.3.2. Independent Pharmacy

        9.3.3. Online Platform

        9.3.4. Clinics

        9.3.5. Others

    9.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        9.4.1. Germany

        9.4.2. France

        9.4.3. U.K.

        9.4.4. Spain

        9.4.5. Italy

        9.4.6. Russia

        9.4.7. Rest of Europe

    9.5. Market Attractiveness Analysis

        9.5.1. By Product

        9.5.2. By Distribution Channel

        9.5.3. By Country/Sub-region

10. Asia Pacific Contraceptives Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Policies and Regulations

        10.1.3. Key Trends

    10.2. Market Value Forecast, by Product, 2017–2028

        10.2.1. Contraceptive Drugs

            10.2.1.1. Oral Contraceptives

                10.2.1.1.1. Combined Contraceptives

                10.2.1.1.2. Mini-pills

            10.2.1.2. Contraceptive Injectable

            10.2.1.3. Topical Contraceptive Patch

        10.2.2. Contraceptive Devices

            10.2.2.1. Male Contraceptive Devices

            10.2.2.2. Female Contraceptive Devices

                10.2.2.2.1. Female Condoms

                10.2.2.2.2. Contraceptive Diaphragms

                10.2.2.2.3. Contraceptive Sponges

                10.2.2.2.4. Contraceptive Vaginal Rings

                10.2.2.2.5. Intrauterine Devices

                10.2.2.2.6. Sub-dermal Contraceptives Implants

                10.2.2.2.7. Non-Surgical Permanent Contraception Devices

    10.3. Market Value Forecast, by Distribution Channel, 2017–2028

        10.3.1. Hospital Pharmacy

            10.3.1.1. Public

            10.3.1.2. Private

        10.3.2. Independent Pharmacy

        10.3.3. Online Platforms

        10.3.4. Clinics

        10.3.5. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        10.4.1. China

        10.4.2. Japan

        10.4.3. India

        10.4.4. Australia & New Zealand

        10.4.5. Rest of Asia Pacific

    10.5. Market Attractiveness Analysis

        10.5.1. By Product

        10.5.2. By Distribution Channel

        10.5.3. By Country/Sub-region

11. Latin America Contraceptives Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Policies and Regulations

        11.1.3. Key Trends

    11.2. Market Value Forecast, by Product, 2017–2028

        11.2.1. Contraceptive Drugs

            11.2.1.1. Oral Contraceptives

                11.2.1.1.1. Combined Contraceptives

                11.2.1.1.2. Mini-pills

            11.2.1.2. Contraceptive Injectable

            11.2.1.3. Topical Contraceptive Patch

        11.2.2. Contraceptive Devices

            11.2.2.1. Male Contraceptive Devices

            11.2.2.2. Female Contraceptive Devices

                11.2.2.2.1. Female Condoms

                11.2.2.2.2. Contraceptive Diaphragms

                11.2.2.2.3. Contraceptive Sponges

                11.2.2.2.4. Contraceptive Vaginal Rings

                11.2.2.2.5. Intrauterine Devices

                11.2.2.2.6. Sub-dermal Contraceptives Implants

                11.2.2.2.7. Non-Surgical Permanent Contraception Devices

    11.3. Market Value Forecast, by Distribution Channel, 2017–2028

        11.3.1. Hospital Pharmacy

            11.3.1.1. Public

            11.3.1.2. Private

        11.3.2. Independent Pharmacy

        11.3.3. Online Platforms

        11.3.4. Clinics

        11.3.5. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2028

        11.4.1. Brazil

        11.4.2. Mexico

        11.4.3. Rest of Latin America

    11.5. Market Attractiveness Analysis

        11.5.1. By Product

        11.5.2. By Distribution Channel

        11.5.3. By Country/Sub-region

12. Middle East and Africa Contraceptives Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Policies and Regulations

        12.1.3. Key Trends

    12.2. Market Value Forecast, by Product, 2017–2028

        12.2.1. Contraceptive Drugs

            12.2.1.1. Oral Contraceptives

                12.2.1.1.1. Combined Contraceptives

                12.2.1.1.2. Mini-pills

            12.2.1.2. Contraceptive Injectable

            12.2.1.3. Topical Contraceptive Patch

        12.2.2. Contraceptive Devices

            12.2.2.1. Male Contraceptive Devices

            12.2.2.2. Female Contraceptive Devices

                12.2.2.2.1. Female Condoms

                12.2.2.2.2. Contraceptive Diaphragms

                12.2.2.2.3. Contraceptive Sponges

                12.2.2.2.4. Contraceptive Vaginal Rings

                12.2.2.2.5. Intrauterine Devices

                12.2.2.2.6. Sub-dermal Contraceptives Implants

                12.2.2.2.7. Non-Surgical Permanent Contraception Devices

    12.3. Market Value Forecast, by End User, 2017–2028

        12.3.1. Hospital Pharmacy

            12.3.1.1. Public

            12.3.1.2. Private

        12.3.2. Independent Pharmacy

        12.3.3. Online Platform

        12.3.4. Clinics

        12.3.5. Others

    12.4. Market Value Forecast, by Country /Sub-region, 2017–2028

        12.4.1. GCC Countries

        12.4.2. South Africa

        12.4.3. Rest of Middle East and Africa

    12.5. Market Attractiveness Analysis

        12.5.1. By Product

        12.5.2. By Distribution Channel

        12.5.3. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player - Competition Matrix (by tier and size of companies)

    13.2. Market Share Analysis, by Company, 2020

    13.3. Company Profiles

        13.3.1. Merck & Co., Inc.

            13.3.1.1. Overview

            13.3.1.2. Financials

            13.3.1.3. Recent Developments

            13.3.1.4. Strategy

        13.3.2. Cipla, Inc.

            13.3.2.1. Overview

            13.3.2.2. Financials

            13.3.2.3. Recent Developments

            13.3.2.4. Strategy

        13.3.3. Allergan plc

            13.3.3.1. Overview

            13.3.3.2. Financials

            13.3.3.3. Recent Developments

            13.3.3.4. Strategy

        13.3.4. Bayer AG

            13.3.4.1. Overview

            13.3.4.2. Financials

            13.3.4.3. Recent Developments

            13.3.4.4. Strategy

        13.3.5. HLL Lifecare Limited

            13.3.5.1. Overview

            13.3.5.2. Financials

            13.3.5.3. Recent Developments

            13.3.5.4. Strategy

        13.3.6. Mankind Pharma

            13.3.6.1. Overview

            13.3.6.2. Financials

            13.3.6.3. Recent Developments

            13.3.6.4. Strategy

        13.3.7. Pfizer, Inc.

            13.3.7.1. Overview

            13.3.7.2. Financials

            13.3.7.3. Recent Developments

            13.3.7.4. Strategy

        13.3.8. Teva Pharmaceutical Industries Ltd.

            13.3.8.1. Overview

            13.3.8.2. Financials

            13.3.8.3. Recent Developments

            13.3.8.4. Strategy

        13.3.9. Mithra Pharmaceuticals

            13.3.9.1. Overview

            13.3.9.2. Financials

            13.3.9.3. Recent Developments

            13.3.9.4. Strategy

        13.3.10. Janssen Pharmaceutical Company

            13.3.10.1. Overview

            13.3.10.2. Financials

            13.3.10.3. Recent Developments

            13.3.10.4. Strategy

        13.3.11. Reckitt Benckiser Group plc

            13.3.11.1. Overview

            13.3.11.2. Financials

            13.3.11.3. Recent Developments

            13.3.11.4. Strategy

List of Tables

Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028

Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028

Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028

Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028

Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028

Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028

Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2017–2028

Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2017–2028

Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028

Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028

Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028

Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028

Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028

Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028

Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028

Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028

Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028

Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028

Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028

Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028

Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028

Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028

Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028

Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028

Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028

Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028

Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028

Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028

Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028

Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028

Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028

Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028

Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017–2028

Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017–2028

Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017–2028

Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017–2028

Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017–2028

Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2028

Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017–2028

List of Figures

Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2017–2028

Figure 02: Global Contraceptives Market Value Share, by Product (2020)

Figure 03: Global Contraceptives Market Value Share, by Distribution Channel, 2020

Figure 04: Global Contraceptives Market Value Share, by Region, 2020

Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2028

Figure 06: Global Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028

Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2028

Figure 08: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Drugs, 2017–2028

Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2028

Figure 10: Global Contraceptives Market Attractiveness Analysis, by Oral Contraceptives, 2017–2028

Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2028

Figure 12: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Devices, 2017–2028

Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2028

Figure 14: Global Contraceptives Market Attractiveness Analysis, by Female Contraceptive Devices, 2017–2028

Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 2017–2028

Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2017–2028

Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

Figure 18: Global Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028

Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2017–2028

Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2017–2028

Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2017–2028

Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2017–2028

Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2028

Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2028

Figure 25: Global Contraceptives Market Attractiveness Analysis, by Region, 2017–2028

Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 27: North America Contraceptives Market Attractiveness Analysis, by Country 2017–2028

Figure 28: North America Contraceptives Market Value Share, by Country, 2017 and 2028

Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2028

Figure 30: North America Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028

Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

Figure 32: North America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028

Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 34: Europe Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028

Figure 35: Europe Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2028

Figure 37: Europe Contraceptives Market Attractiveness Analysis, by Product, 2017–2028

Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

Figure 39: Europe Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028

Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 41: Asia Pacific Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028

Figure 42: Asia Pacific Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2028

Figure 44: Asia Pacific Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028

Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

Figure 46: Asia Pacific Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028

Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 48: Latin America Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028

Figure 49: Latin America Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2028

Figure 51: Latin America Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028

Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

Figure 53: Latin America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028

Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028

Figure 55: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017–2028

Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2028

Figure 58: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Product Type, 2017–2028

Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

Figure 60: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017–2028

Figure 61: Global Contraceptives Drugs Market Share, by Company, 2020

Figure 62: Global Contraceptives Devices Market Share, by Company, 2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

560

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved